TrialNature medicine2023
Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial.
Eugene Shenderov et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
80 papers cite itlatest 60 shown
this paperpooled ittrialcites it